陕西省政府支持社会力量全面发展中医药服务

2018-02-27 赵文 中国中医

日前,陕西省政府印发《支持社会力量提供多层次多样化医疗服务实施方案》,提出要充分利用和支持全社会力量,提供包括中医药在内的多层次多样化的医疗服务。

日前,陕西省政府印发《支持社会力量提供多层次多样化医疗服务实施方案》,提出要充分利用和支持全社会力量,提供包括中医药在内的多层次多样化的医疗服务。

《方案》提出,要从4个方面激发市场活力;一是放宽市场准入,对社会办医疗机构设备配置条件适度放宽,按照非公立医疗机构设备配备不低于20%的比例预留规划空间;二是优化审批服务,鼓励健康服务企业品牌化、连锁化经营,落实连锁企业由总部统一办理工商注册登记手续的政策;三是引入战略投资,鼓励公立医院与社会力量合作举办新的非营利性医疗机构,并在人才、管理、服务、技术、品牌等方面建立协议合作关系;四是扩大行业开放,鼓励举办面向境外消费者的社会办中医医疗机构,积极参与面向全球的中医药服务贸易促进体系建设。

《方案》要求从7个领域推动多元化专业化服务发展,其中提出,全面发展中医药服务,鼓励社会力量提供中医医疗、养生保健、康复等服务;鼓励有实力的社会力量办中医诊所和门诊部(中医馆、国医堂)等机构连锁经营,打造陕西品牌;支持咸阳、铜川等地打造中医药文化氛围浓郁的中医药服务区域,提供中医药诊疗、治未病、康复等多元化服务;推进西安、咸阳、铜川、汉中、安康、商洛等地国家中医药健康旅游示范区、示范基地和示范项目建设。同时,推动发展多业态融合服务,促进医疗与养老、旅游、体育等融合发展,推进健康养老产业基地建设,打造高端医疗、中医药服务、康复疗养、休闲养生等健康旅游产业。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2058803, encodeId=eabe2058803cc, content=<a href='/topic/show?id=a656e395691' target=_blank style='color:#2F92EE;'>#社会力量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73956, encryptionId=a656e395691, topicName=社会力量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Tue Jan 29 18:11:00 CST 2019, time=2019-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968595, encodeId=0c36196859590, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Wed Jan 16 01:11:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409371, encodeId=8cac14093e1d4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Mar 01 00:11:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616827, encodeId=052a161682e21, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Mar 01 00:11:00 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2058803, encodeId=eabe2058803cc, content=<a href='/topic/show?id=a656e395691' target=_blank style='color:#2F92EE;'>#社会力量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73956, encryptionId=a656e395691, topicName=社会力量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Tue Jan 29 18:11:00 CST 2019, time=2019-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968595, encodeId=0c36196859590, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Wed Jan 16 01:11:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409371, encodeId=8cac14093e1d4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Mar 01 00:11:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616827, encodeId=052a161682e21, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Mar 01 00:11:00 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2058803, encodeId=eabe2058803cc, content=<a href='/topic/show?id=a656e395691' target=_blank style='color:#2F92EE;'>#社会力量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73956, encryptionId=a656e395691, topicName=社会力量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Tue Jan 29 18:11:00 CST 2019, time=2019-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968595, encodeId=0c36196859590, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Wed Jan 16 01:11:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409371, encodeId=8cac14093e1d4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Mar 01 00:11:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616827, encodeId=052a161682e21, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Mar 01 00:11:00 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-01 hb2008ye
  4. [GetPortalCommentsPageByObjectIdResponse(id=2058803, encodeId=eabe2058803cc, content=<a href='/topic/show?id=a656e395691' target=_blank style='color:#2F92EE;'>#社会力量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73956, encryptionId=a656e395691, topicName=社会力量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Tue Jan 29 18:11:00 CST 2019, time=2019-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968595, encodeId=0c36196859590, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Wed Jan 16 01:11:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409371, encodeId=8cac14093e1d4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Mar 01 00:11:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616827, encodeId=052a161682e21, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Mar 01 00:11:00 CST 2018, time=2018-03-01, status=1, ipAttribution=)]